Age and immunity: What is “immunosenescence”?

&NA; As is apparent from the many contributions to this Special Issue of the Journal, the impact of age on immunity is nefarious, with all manner of dysregulated responses attributed to “immunosenescence”. These range from poorer responses to vaccination, lower capacity to mediate anti‐cancer responses, more inflammation and tissue damage, along with autoimmunity and loss of control of persistent infections. Given the grave clinical implications of altered immune status in aged people, it is of paramount importance to understand the nature of and mechanisms responsible for “immunosenescence”. As in any rapidly developing research area, certain paradigms establish themselves early on, by necessity based on earlier and fewer data, and have a disproportionate influence on how investigators think about the subject, especially investigators from other disciplines. It may therefore be appropriate to reconsider our basic knowledge at this juncture, asking exactly what do we mean by the term “immunosenescence”? This is attempted in this contribution to the Special Issue. HighlightsOpinion on the nature of immunosenescenceOpinion on inflammageingImportance of longitudinal studies in humans

[1]  G. Pawelec,et al.  Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly1 , 2006, The Journal of Immunology.

[2]  H. Hackstein,et al.  Continuous cytomegalovirus seroconversion in a large group of healthy blood donors , 2004, Vox sanguinis.

[3]  Martin Wiklund,et al.  NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing , 2016, The Journal of cell biology.

[4]  J. Margolick,et al.  Chronic CMV infection in older women: Longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8+ T-cell frequencies with twelve year follow-up , 2014, Experimental Gerontology.

[5]  G. Pawelec,et al.  The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioning , 2006, Mechanisms of Ageing and Development.

[6]  A. D. de Craen,et al.  Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people , 2012, AGE.

[7]  G. Pawelec,et al.  The SENIEUR protocol after 16 years , 2001, Mechanisms of Ageing and Development.

[8]  T. Kirkwood,et al.  CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study , 2015, Aging cell.

[9]  J. Dowd,et al.  Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III , 2008, Epidemiology and Infection.

[10]  R. Koup,et al.  IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[11]  M. Denkinger,et al.  HSC Aging and Senescent Immune Remodeling. , 2015, Trends in immunology.

[12]  R. Aspinall,et al.  Thymic Involution in Aging , 2000, Journal of Clinical Immunology.

[13]  G. Pawelec,et al.  CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  G. Pawelec,et al.  CD4: 8 Ratio Above 5 Is Associated With All-Cause Mortality in CMV-Seronegative Very Old Women Results From the BELFRAIL Study , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  J. Utikal,et al.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.

[16]  G. Pawelec,et al.  An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  G. Pawelec,et al.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. , 2012, Vaccine.

[18]  G. Pawelec,et al.  Pathways to a robust immune response in the elderly. , 2003, Immunology and allergy clinics of North America.

[19]  C. Franceschi,et al.  Complexity of anti-immunosenescence strategies in humans. , 2006, Artificial organs.

[20]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[21]  A. Thiel,et al.  Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans , 2015, The Journal of Immunology.

[22]  L. Ferrucci,et al.  Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide. , 2011, Clinical immunology.

[23]  C. Franceschi,et al.  Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. , 2000, Blood.

[24]  G. Pawelec,et al.  Better immunity in later life: a position paper , 2014, AGE.

[25]  A. D. de Craen,et al.  Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. , 2011, The Journal of general virology.

[26]  G. Pawelec,et al.  Intracellular signalling pathways: targets to reverse immunosenescence , 2017, Clinical and experimental immunology.

[27]  James C. Whisstock,et al.  Perforin and granzymes: function, dysfunction and human pathology , 2015, Nature Reviews Immunology.

[28]  R. Rossi,et al.  Convergence of a diabetes mellitus, protein energy malnutrition, and TB epidemic: the neglected elderly population , 2016, BMC Infectious Diseases.

[29]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[30]  Judith M. Fonville,et al.  The confounded effects of age and exposure history in response to influenza vaccination. , 2016, Vaccine.

[31]  D. Baarle,et al.  Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review , 2016, Experimental Gerontology.

[32]  A. D. de Craen,et al.  Hallmark Features of Immunosenescence Are Absent in Familial Longevity , 2010, The Journal of Immunology.

[33]  G. Pawelec,et al.  Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype? , 2002, European cytokine network.

[34]  D. Farber,et al.  Emerging concepts in tissue-resident T cells: lessons from humans. , 2015, Trends in immunology.

[35]  G. Pawelec,et al.  Aging affects the proportions of T and B cells in a group of elderly men in a developing country—a pilot study from Pakistan , 2013, AGE.

[36]  M. Delorenzi,et al.  Long-lasting stem cell–like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination , 2015, Science Translational Medicine.

[37]  D. Belsky,et al.  Quantification of biological aging in young adults , 2015, Proceedings of the National Academy of Sciences.

[38]  M. Cesari,et al.  Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.

[39]  E. Slagboom,et al.  Latent Infection with Cytomegalovirus Is Associated with Poor Memory CD4 Responses to Influenza A Core Proteins in the Elderly , 2014, The Journal of Immunology.

[40]  G. Pawelec,et al.  No Immune Risk Profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal study , 2007, Experimental Gerontology.

[41]  O. Lesur,et al.  Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. , 2012, Seminars in immunology.

[42]  B. Brown,et al.  Cell Therapy Strategies to Combat Immunosenescence , 2015, Organogenesis.

[43]  N. Manley,et al.  An evolutionary perspective on the mechanisms of immunosenescence. , 2009, Trends in immunology.

[44]  M. Levin.  Immune senescence and vaccines to prevent herpes zoster in older persons. , 2012, Current opinion in immunology.

[45]  G. Kuchel,et al.  T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines , 2016, Front. Immunol..

[46]  K. Hirokawa,et al.  Altered T cell signalling in ageing , 2001, Mechanisms of Ageing and Development.

[47]  J. Campisi,et al.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. , 2013, The Journal of clinical investigation.

[48]  Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets , 2015, AGE.

[49]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[50]  T. Makinodan.  Nature of the decline in antigen-induced humoral immunity with age , 1980, Mechanisms of Ageing and Development.

[51]  A. Neumann,et al.  Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells , 2015, AGE.

[52]  Charles H. Yoon,et al.  An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.

[53]  L. Hayflick.  Human cells and aging. , 1968, Scientific American.

[54]  E. Steinhagen-Thiessen,et al.  Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study , 2015, Biogerontology.

[55]  Evelyn Barron,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License Blood-borne Biomarkers of Mortality Risk: Systematic Review of Cohort Studies , 2022 .

[56]  Jeffrey Kaye,et al.  Aging and Cytomegalovirus Infection Differentially and Jointly Affect Distinct Circulating T Cell Subsets in Humans , 2014, The Journal of Immunology.